Not a supplement, drug or food product
After 28 days from first puncture, discard the vial regardless of remaining volume
Earlier this month, (June 2025), Novo inked a deal worth up to $815 million with Deep Apple Therapeutics, a South San Francisco-based company specializing in small-molecule drug discovery to discover, develop, and commercialize oral small-molecule therapeutics directed at a non-incretin G protein-coupled receptors (GPCR) target for cardiometabolic diseases, including obesity, in a deal worth up to $812 million
Using the wrong pen type : Administering Wegovy when prescribed Ozempic (or vice versa) can result in incorrect dosing
Front desk girls are friendly and always helpful too
Routes Subcutaneous (SubQ) injection and topical formulations are the two main research-use routes